Role of Alendronate in Managing Osteoporosis in Celiac Disease – Illustrative Case Report

Management of bone density loss, as the result of calcium malabsorption in celiac disease, is critical in preventing premature bone fracture. As many of these patients need follow-up with primary care providers, internists are expected to be aware of screening and prompt management of osteopenia or...

Descripción completa

Detalles Bibliográficos
Autores principales: Widjaja, David, Kanneganti, Kalyan C., Patel, Madanmohan, Chilimuri, Sridhar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139797/
https://www.ncbi.nlm.nih.gov/pubmed/27957009
http://dx.doi.org/10.4021/gr279w
Descripción
Sumario:Management of bone density loss, as the result of calcium malabsorption in celiac disease, is critical in preventing premature bone fracture. As many of these patients need follow-up with primary care providers, internists are expected to be aware of screening and prompt management of osteopenia or osteoporosis in celiac disease. We present a case of a 32-year-old man with celiac disease who was diagnosed with osteoporosis. He was treated with calcium, vitamin D and alendronate which improved bone mineral density. This case illustrates the importance of using bisphosphonate in treating osteoporosis in celiac disease.

Ejemplares similares